Document Detail


The microeconomics of personalized medicine: today's challenge and tomorrow's promise.
MedLine Citation:
PMID:  19300459     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
'Personalized medicine' promises to increase the quality of clinical care and, in some cases, decrease health-care costs. Despite this, only a handful of diagnostic tests have made it to market, with mixed success. Historically, the challenges in this field were scientific. However, as discussed in this article, with the maturation of the '-omics' sciences, it now seems that the major barriers are increasingly related to economics. Overcoming the poor microeconomic alignment of incentives among key stakeholders is therefore crucial to catalysing the further development and adoption of personalized medicine, and we propose several actions that could help achieve this goal.
Authors:
Jerel C Davis; Laura Furstenthal; Amar A Desai; Troy Norris; Saumya Sutaria; Edd Fleming; Philip Ma
Related Documents :
20139869 - Mid-level providers in gastroenterology.
19233679 - Management strategies for interrupted aortic arch with associated anomalies.
10262409 - Are you managing a future national medical practice?
12615389 - Epilogue: regional development of travel medicine--the saudi challenge.
8739069 - Routine neonatal circumcision: symbol of the birth of the therapeutic state.
12352769 - Stop the spinning: diagnosing and managing vertigo.
10496509 - Self-reported health, and illness and the use of conventional and unconventional medici...
10521889 - Violent crime in an elderly demented patient.
20188299 - Avian influenza--a review for doctors in travel medicine.
Publication Detail:
Type:  Journal Article     Date:  2009-03-20
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  8     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-01     Completed Date:  2009-04-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  279-86     Citation Subset:  IM    
Affiliation:
McKinsey, 3075A Hansen Way, Palo Alto, California 94304, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Delivery of Health Care / economics,  trends
Diagnostic Tests, Routine / economics,  trends
Drug Industry / economics,  trends
Economics / trends*
Humans
Personal Health Services / economics*,  trends
Pharmaceutical Preparations / economics
Pharmacogenetics / economics,  trends
Chemical
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physicians' opinion for 'new' genetic testing in Japan.
Next Document:  Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules.